Back to the drawing board: The FACTS 001 trial, a study to test whether tenofovir gel could prevent HIV infection, did not confirm the gel’s effectiveness. While these results are disappointing, USAID is supporting the development of many other promising solutions, including vaginal rings and long-acting injectables.
